Your browser doesn't support javascript.
loading
Unraveling the Puzzle: Oocyte Maturation Abnormalities (OMAS).
Hatirnaz, Safak; Hatirnaz, Ebru; Çelik, Samettin; Çaliskan, Canan Soyer; Tinelli, Andrea; Malvasi, Antonio; Sparic, Radmila; Baldini, Domenico; Stark, Michael; Dahan, Michael H.
Afiliación
  • Hatirnaz S; Mediliv Medical Center, Samsun 55100, Turkey.
  • Hatirnaz E; Mediliv Medical Center, Samsun 55100, Turkey.
  • Çelik S; Department of Obstetrics and Gynecology, Samsun Training and Research Hospital, Samsun 55090, Turkey.
  • Çaliskan CS; Department of Obstetrics and Gynecology, Samsun Training and Research Hospital, Samsun 55090, Turkey.
  • Tinelli A; Department of Obstetrics and Gynecology and CERICSAL (CEntro di RIcercaClinicoSALentino), Verisdelli Ponti Hospital, 73020 Scorrano, Italy.
  • Malvasi A; Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynecology Section, University of Bari "Aldo Moro", Piazza Aldo Moro, 70100 Bari, Italy.
  • Sparic R; Medical Faculty, Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
  • Baldini D; MomòFertilife Clinic, 76011 Bisceglie, Italy.
  • Stark M; The New European Surgical Academy (NESA), 10117 Berlin, Germany.
  • Dahan MH; McGill University Health Center Reproductive Centre, Department of ObGyn, McGill University, Montreal, QC H3A 0G4, Canada.
Diagnostics (Basel) ; 12(10)2022 Oct 15.
Article en En | MEDLINE | ID: mdl-36292190
Oocyte maturation abnormalities (OMAS) are a poorly understood area of reproductive medicine. Much remains to be understood about how OMAS occur. However, current knowledge has provided some insight into the mechanistic and genetic origins of this syndrome. In this study, current classifications of OMAS syndromes are discussed and areas of inadequacy are highlighted. We explain why empty follicle syndrome, dysmorphic oocytes, some types of premature ovarian insufficiency and resistant ovary syndrome can cause OMAS. We discuss live births in different types of OMAS and when subjects can be offered treatment with autologous oocytes. As such, we present this review of the mechanism and understanding of OMAS to better lead the clinician in understanding this difficult-to-treat diagnosis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diagnostics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diagnostics (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Turquía
...